PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI,titre_abstract_interessant,papier_entier_interessant,commentaire
31952493,The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial,"Abdulla A, Ewoldt TMJ, Hunfeld NGM, Muller AE, Rietdijk WJR, Polinder S, van Gelder T, Endeman H, Koch BCP.",BMC Infect Dis. 2020 Jan 17;20(1):57. doi: 10.1186/s12879-020-4781-x.,Abdulla A,BMC Infect Dis,2020,2020/01/19,PMC6969462,,10.1186/s12879-020-4781-x,non,,
23800901,Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients,"Carlier M, Noë M, De Waele JJ, Stove V, Verstraete AG, Lipman J, Roberts JA.",J Antimicrob Chemother. 2013 Nov;68(11):2600-8. doi: 10.1093/jac/dkt240. Epub 2013 Jun 25.,Carlier M,J Antimicrob Chemother,2013,2013/06/27,,,10.1093/jac/dkt240,oui,,amox+acide clavulanique
34869739,Population Pharmacokinetics of Intravenous Amoxicillin Combined With Clavulanic Acid in Healthy and Critically Ill Dogs,"Vegas Cómitre MD, Cortellini S, Cherlet M, Devreese M, Roques BB, Bousquet-Melou A, Toutain PL, Pelligand L.",Front Vet Sci. 2021 Nov 15;8:770202. doi: 10.3389/fvets.2021.770202. eCollection 2021.,Vegas Cómitre MD,Front Vet Sci,2021,2021/12/06,PMC8636140,,10.3389/fvets.2021.770202,??? non ?,,amox+acide clavulanique ; PK de pop MAIS chez le chien
29914948,Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center,"Fournier A, Goutelle S, Que YA, Eggimann P, Pantet O, Sadeghipour F, Voirol P, Csajka C.",Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00505-18. doi: 10.1128/AAC.00505-18. Print 2018 Sep.,Fournier A,Antimicrob Agents Chemother,2018,2018/06/20,PMC6125536,,10.1128/AAC.00505-18,oui,,amox ; burn patients 
33227230,Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?,Marsot A.,J Pharm Pharm Sci. 2020;23:470-485. doi: 10.18433/jpps30927.,Marsot A,J Pharm Pharm Sci,2020,2020/11/23,,,10.18433/jpps30927,non ? ,,"review ; description des paramètres PK et covariables chez des enfants, s'appuie notamment sur des études décrivant la Pk de pop de l'amoxicilline chez les enfants "
26349821,Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children,"De Cock PA, Standing JF, Barker CI, de Jaeger A, Dhont E, Carlier M, Verstraete AG, Delanghe JR, Robays H, De Paepe P.",Antimicrob Agents Chemother. 2015 Nov;59(11):7027-35. doi: 10.1128/AAC.01368-15. Epub 2015 Sep 8.,De Cock PA,Antimicrob Agents Chemother,2015,2015/09/10,PMC4604416,,10.1128/AAC.01368-15,oui,,amox + ac clavulanique ; chez des enfants
32933574,Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT),"Abdulla A, Dijkstra A, Hunfeld NGM, Endeman H, Bahmany S, Ewoldt TMJ, Muller AE, van Gelder T, Gommers D, Koch BCP.",Crit Care. 2020 Sep 15;24(1):558. doi: 10.1186/s13054-020-03272-z.,Abdulla A,Crit Care,2020,2020/09/16,PMC7493358,,10.1186/s13054-020-03272-z,non,,
